famotidine has been researched along with Dyspnea in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Dyspnea: Difficult or labored breathing.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, YI | 1 |
| Park, CK | 1 |
| Park, DJ | 1 |
| Wi, JO | 1 |
| Han, ER | 1 |
| Koh, YI | 1 |
1 other study available for famotidine and Dyspnea
| Article | Year |
|---|---|
A case of famotidine-induced anaphylaxis.
Topics: Adrenal Cortex Hormones; Anaphylaxis; Coma; Cross Reactions; Drug Hypersensitivity; Dyspnea; Epineph | 2010 |